Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp384
|
ENSMUSG00000038346.12 | zinc finger protein 384 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_125009743_125009966 | Zfp384 | 49 | 0.936241 | 0.54 | 2.5e-05 | Click! |
chr6_125008651_125009067 | Zfp384 | 286 | 0.781227 | 0.47 | 2.6e-04 | Click! |
chr6_125009531_125009725 | Zfp384 | 41 | 0.937975 | 0.36 | 7.3e-03 | Click! |
chr6_125009181_125009461 | Zfp384 | 38 | 0.938560 | 0.21 | 1.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_57784462_57784659 | 15.13 |
Fabp7 |
fatty acid binding protein 7, brain |
321 |
0.86 |
chr15_25754647_25755340 | 14.64 |
Myo10 |
myosin X |
2014 |
0.38 |
chr12_3236518_3237725 | 13.62 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr2_94265618_94265929 | 13.00 |
Mir670hg |
MIR670 host gene (non-protein coding) |
855 |
0.53 |
chr16_87698379_87699046 | 12.70 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
233 |
0.94 |
chr14_77593599_77594006 | 12.36 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
20946 |
0.17 |
chrX_143932561_143932819 | 12.35 |
Dcx |
doublecortin |
360 |
0.92 |
chr9_37359459_37360109 | 11.91 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chr10_87489547_87489770 | 11.55 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
4002 |
0.23 |
chr14_118230672_118230848 | 11.43 |
Gm4675 |
predicted gene 4675 |
5472 |
0.14 |
chrY_90739614_90740540 | 11.29 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr17_52600562_52601051 | 11.19 |
Gm27217 |
predicted gene 27217 |
1854 |
0.34 |
chr8_78340927_78341109 | 11.17 |
Ttc29 |
tetratricopeptide repeat domain 29 |
49964 |
0.15 |
chr9_124439906_124440949 | 11.08 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr3_19406344_19406802 | 10.86 |
Pde7a |
phosphodiesterase 7A |
95251 |
0.07 |
chr7_61939801_61940302 | 10.74 |
Mir344-2 |
microRNA 344-2 |
55 |
0.95 |
chr9_23378360_23378672 | 10.68 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr7_69572743_69572908 | 10.53 |
Gm44535 |
predicted gene 44535 |
6883 |
0.22 |
chr13_84344282_84344641 | 10.52 |
Gm26927 |
predicted gene, 26927 |
4348 |
0.26 |
chr1_31233663_31234000 | 10.22 |
Pih1d3 |
PIH1 domain containing 3 |
10993 |
0.12 |
chr14_118230141_118230337 | 9.96 |
Gm4675 |
predicted gene 4675 |
5993 |
0.14 |
chr14_19977078_19977720 | 9.84 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
150 |
0.96 |
chr11_75509773_75510993 | 9.77 |
Rilp |
Rab interacting lysosomal protein |
84 |
0.93 |
chr6_141495881_141496061 | 9.75 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
28397 |
0.2 |
chr10_51153468_51153678 | 9.70 |
Gm26257 |
predicted gene, 26257 |
28726 |
0.22 |
chr2_70126801_70127190 | 9.63 |
Myo3b |
myosin IIIB |
30697 |
0.2 |
chr14_55108634_55109060 | 9.45 |
Jph4 |
junctophilin 4 |
1711 |
0.17 |
chr7_25178979_25179293 | 9.41 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
590 |
0.58 |
chr17_90892371_90892658 | 9.36 |
4930480K15Rik |
RIKEN cDNA 4930480K15 gene |
31345 |
0.22 |
chr16_77593811_77594374 | 9.25 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
264 |
0.83 |
chr2_51753317_51753685 | 8.93 |
Gm13490 |
predicted gene 13490 |
21492 |
0.21 |
chr4_110287770_110287961 | 8.81 |
Elavl4 |
ELAV like RNA binding protein 4 |
338 |
0.93 |
chr1_173390169_173390349 | 8.80 |
Cadm3 |
cell adhesion molecule 3 |
22564 |
0.14 |
chr10_118102987_118104071 | 8.58 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chr3_17788774_17789074 | 8.53 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
997 |
0.54 |
chr8_36457363_36458468 | 8.51 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr5_98180681_98181156 | 8.51 |
Prdm8 |
PR domain containing 8 |
60 |
0.97 |
chr2_136108440_136108709 | 8.44 |
Gm14218 |
predicted gene 14218 |
28432 |
0.19 |
chr7_99267195_99268129 | 8.33 |
Map6 |
microtubule-associated protein 6 |
173 |
0.76 |
chrX_10992556_10992988 | 8.27 |
Gm14485 |
predicted gene 14485 |
28235 |
0.23 |
chr3_52007969_52008225 | 8.25 |
Gm37465 |
predicted gene, 37465 |
4072 |
0.15 |
chr8_53511625_53512278 | 8.22 |
Aga |
aspartylglucosaminidase |
153 |
0.96 |
chr5_103911497_103911895 | 8.21 |
Klhl8 |
kelch-like 8 |
437 |
0.79 |
chr10_57784677_57785037 | 8.18 |
Fabp7 |
fatty acid binding protein 7, brain |
24 |
0.97 |
chr2_71517791_71517985 | 8.17 |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
2476 |
0.2 |
chr8_96455488_96455681 | 8.15 |
Gm32122 |
predicted gene, 32122 |
51722 |
0.14 |
chr8_118379787_118379998 | 8.14 |
Gm45722 |
predicted gene 45722 |
2299 |
0.37 |
chr5_149495653_149495848 | 8.12 |
Gm2566 |
predicted gene 2566 |
7302 |
0.14 |
chr9_41697271_41698297 | 8.06 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr1_94503928_94504626 | 8.05 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chr14_55054475_55054712 | 8.01 |
Gm20687 |
predicted gene 20687 |
352 |
0.58 |
chr2_105282496_105282697 | 7.99 |
Them7 |
thioesterase superfamily member 7 |
58254 |
0.13 |
chr12_49945277_49945719 | 7.99 |
Gm7481 |
predicted gene 7481 |
103747 |
0.08 |
chr1_81520769_81521201 | 7.98 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr13_6307436_6307642 | 7.97 |
Gm35615 |
predicted gene, 35615 |
12825 |
0.23 |
chr6_127766930_127768435 | 7.85 |
Gm42738 |
predicted gene 42738 |
140 |
0.91 |
chrX_135797004_135797466 | 7.77 |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
353 |
0.46 |
chr11_41532495_41533004 | 7.77 |
Hspd1-ps3 |
heat shock protein 1 (chaperonin), pseudogene 3 |
34012 |
0.2 |
chr13_113917716_113918082 | 7.74 |
Arl15 |
ADP-ribosylation factor-like 15 |
123277 |
0.05 |
chr8_127706452_127706870 | 7.72 |
Gm22968 |
predicted gene, 22968 |
108955 |
0.07 |
chr11_16257044_16257441 | 7.67 |
Vstm2a |
V-set and transmembrane domain containing 2A |
482 |
0.85 |
chr13_83732174_83732508 | 7.60 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
225 |
0.89 |
chr12_49484164_49484347 | 7.56 |
1810007C17Rik |
RIKEN cDNA 1810007C17 gene |
3393 |
0.24 |
chr5_44976010_44976188 | 7.53 |
Gm10205 |
predicted gene 10205 |
8143 |
0.21 |
chr7_73917720_73918558 | 7.52 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr8_55034331_55034668 | 7.45 |
Gm45264 |
predicted gene 45264 |
6098 |
0.14 |
chr13_84571624_84571828 | 7.38 |
Gm26913 |
predicted gene, 26913 |
119215 |
0.06 |
chr9_15774617_15774937 | 7.35 |
Slc36a4 |
solute carrier family 36 (proton/amino acid symporter), member 4 |
47889 |
0.12 |
chr3_68513686_68514094 | 7.33 |
Schip1 |
schwannomin interacting protein 1 |
19682 |
0.2 |
chr19_47014205_47014413 | 7.32 |
Ina |
internexin neuronal intermediate filament protein, alpha |
389 |
0.67 |
chr19_41746384_41746957 | 7.32 |
Slit1 |
slit guidance ligand 1 |
3005 |
0.27 |
chr4_116016940_116018214 | 7.31 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr13_28810739_28811035 | 7.16 |
Gm17528 |
predicted gene, 17528 |
16236 |
0.19 |
chr2_45024539_45024913 | 7.15 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
1056 |
0.47 |
chr6_22833658_22833979 | 7.14 |
Gm43629 |
predicted gene 43629 |
28489 |
0.15 |
chr12_88800772_88801300 | 7.12 |
Nrxn3 |
neurexin III |
5597 |
0.29 |
chr18_32378202_32378647 | 7.10 |
A830052D11Rik |
RIKEN cDNA A830052D11 gene |
146 |
0.93 |
chr15_59040434_59041094 | 7.10 |
Mtss1 |
MTSS I-BAR domain containing 1 |
167 |
0.96 |
chr13_105256983_105257274 | 7.10 |
Rnf180 |
ring finger protein 180 |
13911 |
0.24 |
chr18_16703519_16704021 | 7.09 |
Gm15485 |
predicted gene 15485 |
24963 |
0.21 |
chr15_103518379_103518595 | 7.06 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
3567 |
0.17 |
chr6_15408824_15408992 | 7.02 |
Gm25470 |
predicted gene, 25470 |
3927 |
0.31 |
chr2_49618925_49619098 | 7.01 |
Kif5c |
kinesin family member 5C |
287 |
0.94 |
chr10_46827266_46827417 | 6.99 |
Gm25650 |
predicted gene, 25650 |
11166 |
0.24 |
chr9_61102260_61102431 | 6.99 |
4933433G08Rik |
RIKEN cDNA 4933433G08 gene |
3040 |
0.19 |
chr16_64264966_64265117 | 6.97 |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
214107 |
0.02 |
chr2_65668417_65668738 | 6.96 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
109 |
0.98 |
chr19_14436131_14436458 | 6.95 |
Tle4 |
transducin-like enhancer of split 4 |
159245 |
0.04 |
chr15_13392917_13393530 | 6.91 |
Gm8238 |
predicted gene 8238 |
25633 |
0.22 |
chr9_83806172_83806700 | 6.89 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr13_83885788_83885966 | 6.89 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
5331 |
0.24 |
chrX_35888186_35888814 | 6.87 |
Dock11 |
dedicator of cytokinesis 11 |
332 |
0.91 |
chr9_44721587_44722104 | 6.86 |
Phldb1 |
pleckstrin homology like domain, family B, member 1 |
421 |
0.66 |
chr9_36821327_36821662 | 6.84 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
370 |
0.82 |
chr8_12126666_12127044 | 6.84 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
151964 |
0.03 |
chr13_29826518_29826793 | 6.82 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
28776 |
0.23 |
chr5_53276737_53276959 | 6.81 |
Smim20 |
small integral membrane protein 20 |
270 |
0.91 |
chr16_42575508_42575977 | 6.80 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr1_42687059_42687229 | 6.80 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
5949 |
0.15 |
chr6_129533069_129533908 | 6.79 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
63 |
0.68 |
chr15_88979147_88979331 | 6.79 |
Mlc1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human) |
232 |
0.84 |
chr4_22494880_22495651 | 6.76 |
Gm30731 |
predicted gene, 30731 |
4717 |
0.18 |
chr8_89324466_89324831 | 6.75 |
Gm5356 |
predicted pseudogene 5356 |
137088 |
0.05 |
chr1_190727415_190727906 | 6.74 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
82803 |
0.09 |
chr13_83744885_83745867 | 6.74 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr19_14301460_14301660 | 6.74 |
Gm26993 |
predicted gene, 26993 |
283189 |
0.01 |
chr8_55026049_55026477 | 6.74 |
Gm45264 |
predicted gene 45264 |
2138 |
0.23 |
chr19_59006883_59007106 | 6.74 |
Shtn1 |
shootin 1 |
31291 |
0.15 |
chr1_184066363_184066753 | 6.73 |
Dusp10 |
dual specificity phosphatase 10 |
32177 |
0.18 |
chr6_81660570_81661025 | 6.73 |
Gm26264 |
predicted gene, 26264 |
22486 |
0.22 |
chr18_25754808_25755256 | 6.72 |
Celf4 |
CUGBP, Elav-like family member 4 |
875 |
0.66 |
chr12_35008006_35008205 | 6.67 |
Prps1l1 |
phosphoribosyl pyrophosphate synthetase 1-like 1 |
23344 |
0.17 |
chrX_13461303_13461893 | 6.66 |
Nyx |
nyctalopin |
4512 |
0.22 |
chr9_37625246_37625717 | 6.66 |
Siae |
sialic acid acetylesterase |
3827 |
0.14 |
chr10_106609605_106610022 | 6.64 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr9_10269473_10269801 | 6.64 |
Gm24496 |
predicted gene, 24496 |
20950 |
0.22 |
chr10_34904244_34904432 | 6.64 |
Gm8834 |
predicted gene 8834 |
6082 |
0.26 |
chr13_4666457_4666651 | 6.64 |
Gm40658 |
predicted gene, 40658 |
22647 |
0.18 |
chr10_25023823_25024169 | 6.63 |
Gm47715 |
predicted gene, 47715 |
23976 |
0.15 |
chr3_45385015_45385410 | 6.62 |
Pcdh10 |
protocadherin 10 |
2579 |
0.24 |
chrX_43429975_43430537 | 6.61 |
Tenm1 |
teneurin transmembrane protein 1 |
1130 |
0.54 |
chr3_116399495_116400013 | 6.59 |
Cdc14a |
CDC14 cell division cycle 14A |
5734 |
0.18 |
chr10_38553365_38553786 | 6.59 |
Gm22911 |
predicted gene, 22911 |
61906 |
0.14 |
chr6_70824227_70825026 | 6.56 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
19889 |
0.13 |
chrX_7639133_7639516 | 6.54 |
Syp |
synaptophysin |
19 |
0.94 |
chr6_111622228_111622411 | 6.51 |
Gm22093 |
predicted gene, 22093 |
19067 |
0.29 |
chr8_7946073_7946224 | 6.51 |
Gm45160 |
predicted gene 45160 |
39220 |
0.19 |
chr16_39303437_39303588 | 6.49 |
Gm36742 |
predicted gene, 36742 |
114606 |
0.06 |
chr14_93416900_93417056 | 6.49 |
Gm48964 |
predicted gene, 48964 |
105841 |
0.07 |
chr12_50120364_50120537 | 6.48 |
Gm40418 |
predicted gene, 40418 |
141 |
0.98 |
chr3_8510910_8511440 | 6.48 |
Stmn2 |
stathmin-like 2 |
1589 |
0.43 |
chr5_37716863_37717819 | 6.46 |
Stk32b |
serine/threonine kinase 32B |
170 |
0.96 |
chr13_83984413_83984945 | 6.45 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr1_151626939_151627090 | 6.43 |
Fam129a |
family with sequence similarity 129, member A |
50153 |
0.12 |
chr16_74397525_74397714 | 6.41 |
Robo2 |
roundabout guidance receptor 2 |
13293 |
0.25 |
chr3_37816924_37817412 | 6.40 |
Gm26404 |
predicted gene, 26404 |
14516 |
0.13 |
chr11_81767736_81768040 | 6.38 |
5530401A14Rik |
RIKEN cDNA 5530401A14 gene |
92785 |
0.08 |
chr17_42316598_42316991 | 6.35 |
Ptchd4 |
patched domain containing 4 |
194 |
0.97 |
chr7_62261961_62262132 | 6.34 |
Gm9801 |
predicted gene 9801 |
52567 |
0.13 |
chr17_13654565_13655321 | 6.29 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chrX_59241531_59241704 | 6.28 |
Gm14890 |
predicted gene 14890 |
44654 |
0.15 |
chrX_166344291_166344543 | 6.28 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr7_119184201_119185061 | 6.24 |
Gpr139 |
G protein-coupled receptor 139 |
28 |
0.98 |
chr1_25107573_25107724 | 6.22 |
Gm29414 |
predicted gene 29414 |
80416 |
0.07 |
chr1_166304269_166304463 | 6.22 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
5219 |
0.2 |
chr12_51117782_51117952 | 6.21 |
Gm7172 |
predicted gene 7172 |
16835 |
0.21 |
chr1_124045941_124046349 | 6.20 |
Dpp10 |
dipeptidylpeptidase 10 |
586 |
0.86 |
chr3_73343261_73343466 | 6.20 |
Gm38353 |
predicted gene, 38353 |
13929 |
0.28 |
chr3_20776476_20776661 | 6.20 |
Gm18491 |
predicted gene, 18491 |
7495 |
0.19 |
chr14_100458942_100459487 | 6.20 |
6330576A10Rik |
RIKEN cDNA 6330576A10 gene |
209 |
0.94 |
chr1_14108993_14109169 | 6.18 |
Gm37400 |
predicted gene, 37400 |
3738 |
0.32 |
chr2_65847807_65847994 | 6.17 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
2045 |
0.35 |
chr6_134219393_134219753 | 6.16 |
Etv6 |
ets variant 6 |
14027 |
0.16 |
chrX_10478991_10479142 | 6.15 |
Tspan7 |
tetraspanin 7 |
6092 |
0.24 |
chr15_102788951_102789137 | 6.15 |
Gm49473 |
predicted gene, 49473 |
6327 |
0.16 |
chr18_14320004_14320155 | 6.15 |
Gm29992 |
predicted gene, 29992 |
11197 |
0.17 |
chr3_108536967_108537149 | 6.14 |
1700013F07Rik |
RIKEN cDNA 1700013F07 gene |
476 |
0.4 |
chr3_41408793_41409655 | 6.12 |
Gm25487 |
predicted gene, 25487 |
32243 |
0.14 |
chr17_52601056_52601789 | 6.11 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr11_78113833_78114090 | 6.10 |
Fam222b |
family with sequence similarity 222, member B |
1645 |
0.18 |
chr9_120869974_120870286 | 6.09 |
Gm34425 |
predicted gene, 34425 |
184 |
0.83 |
chr4_23827011_23827218 | 6.09 |
Gm28448 |
predicted gene 28448 |
106840 |
0.07 |
chr13_24656747_24656902 | 6.09 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
16115 |
0.19 |
chr8_33747955_33748115 | 6.09 |
Smim18 |
small integral membrane protein 18 |
265 |
0.89 |
chrX_143906539_143906984 | 6.08 |
Dcx |
doublecortin |
26289 |
0.21 |
chr2_71244927_71245170 | 6.07 |
Dync1i2 |
dynein cytoplasmic 1 intermediate chain 2 |
10249 |
0.21 |
chr10_17331363_17331552 | 6.06 |
Gm47760 |
predicted gene, 47760 |
1420 |
0.48 |
chr6_58932915_58933165 | 6.06 |
Herc3 |
hect domain and RLD 3 |
25778 |
0.12 |
chr11_28735281_28735484 | 6.06 |
Mir216b |
microRNA 216b |
10809 |
0.13 |
chr18_90031804_90031989 | 6.06 |
Gm6173 |
predicted gene 6173 |
12817 |
0.27 |
chr1_77514307_77515010 | 6.05 |
Epha4 |
Eph receptor A4 |
421 |
0.6 |
chr6_40471817_40472014 | 6.05 |
Ssbp1 |
single-stranded DNA binding protein 1 |
389 |
0.77 |
chr13_59092007_59092498 | 6.05 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
8159 |
0.17 |
chr8_26677359_26677510 | 6.04 |
Gm32098 |
predicted gene, 32098 |
9128 |
0.18 |
chr1_57497384_57497671 | 6.04 |
Gm8581 |
predicted gene 8581 |
21885 |
0.14 |
chr4_24621447_24621743 | 6.04 |
Mms22l |
MMS22-like, DNA repair protein |
42747 |
0.17 |
chr3_114029993_114030781 | 6.01 |
Col11a1 |
collagen, type XI, alpha 1 |
153 |
0.98 |
chr2_45158345_45158770 | 6.01 |
Gm28643 |
predicted gene 28643 |
1632 |
0.43 |
chr3_68139235_68139398 | 6.01 |
Schip1 |
schwannomin interacting protein 1 |
74514 |
0.12 |
chr17_52602043_52602770 | 6.00 |
Gm27217 |
predicted gene 27217 |
254 |
0.55 |
chr17_91092598_91092749 | 6.00 |
Nrxn1 |
neurexin I |
60 |
0.97 |
chr10_78747019_78747870 | 5.99 |
Gm30400 |
predicted gene, 30400 |
285 |
0.85 |
chr1_159413392_159413771 | 5.99 |
Gm37757 |
predicted gene, 37757 |
15379 |
0.17 |
chr3_146319056_146319398 | 5.96 |
Gm43334 |
predicted gene 43334 |
5193 |
0.2 |
chr4_57638055_57638394 | 5.96 |
Pakap |
paralemmin A kinase anchor protein |
249 |
0.95 |
chr8_77518027_77518631 | 5.95 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
214 |
0.67 |
chr17_24736037_24737110 | 5.95 |
Msrb1 |
methionine sulfoxide reductase B1 |
69 |
0.91 |
chr13_97900436_97900712 | 5.95 |
Gm34388 |
predicted gene, 34388 |
23912 |
0.18 |
chr18_23091078_23091294 | 5.94 |
Nol4 |
nucleolar protein 4 |
49533 |
0.16 |
chr14_12393556_12393971 | 5.93 |
Gm48267 |
predicted gene, 48267 |
8467 |
0.14 |
chr16_32608179_32609639 | 5.93 |
Tfrc |
transferrin receptor |
11 |
0.97 |
chrX_136115473_136115666 | 5.93 |
5730412P04Rik |
RIKEN cDNA 5730412P04 gene |
10966 |
0.12 |
chr13_15621156_15621364 | 5.93 |
Gm48343 |
predicted gene, 48343 |
28675 |
0.21 |
chr5_133365953_133366104 | 5.92 |
Gm42625 |
predicted gene 42625 |
77314 |
0.11 |
chr2_65845289_65845528 | 5.90 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
359 |
0.89 |
chr7_133441263_133441473 | 5.90 |
Gm45672 |
predicted gene 45672 |
108167 |
0.06 |
chr12_61522288_61522738 | 5.89 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
637 |
0.47 |
chr1_165935347_165935547 | 5.88 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
436 |
0.79 |
chr13_34133643_34133908 | 5.87 |
Gm36500 |
predicted gene, 36500 |
85 |
0.94 |
chr1_89739598_89739966 | 5.85 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
49381 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.7 | 35.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
6.8 | 27.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
5.3 | 15.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.5 | 18.2 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.5 | 18.0 | GO:0061743 | motor learning(GO:0061743) |
4.5 | 13.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
3.9 | 7.9 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
3.8 | 26.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.7 | 11.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.6 | 14.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.5 | 13.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.5 | 20.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
3.2 | 3.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
3.2 | 9.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.1 | 15.6 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.9 | 26.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
2.9 | 8.7 | GO:0030070 | insulin processing(GO:0030070) |
2.9 | 8.7 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
2.8 | 8.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.8 | 2.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.8 | 8.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
2.7 | 24.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
2.7 | 8.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
2.7 | 2.7 | GO:0021550 | medulla oblongata development(GO:0021550) |
2.5 | 2.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
2.5 | 7.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
2.5 | 10.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
2.5 | 17.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.4 | 7.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.3 | 7.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.3 | 7.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.3 | 7.0 | GO:0021564 | vagus nerve development(GO:0021564) |
2.2 | 4.3 | GO:0021586 | pons maturation(GO:0021586) |
2.2 | 10.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.1 | 2.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.1 | 6.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.1 | 14.8 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
2.1 | 4.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.1 | 29.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
2.1 | 4.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.1 | 2.1 | GO:0099612 | protein localization to axon(GO:0099612) |
2.0 | 6.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.0 | 12.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.0 | 30.2 | GO:0001964 | startle response(GO:0001964) |
2.0 | 6.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.0 | 4.0 | GO:0098597 | observational learning(GO:0098597) |
2.0 | 4.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.0 | 3.9 | GO:0048880 | sensory system development(GO:0048880) |
1.9 | 5.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.9 | 9.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.9 | 5.7 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
1.9 | 5.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.8 | 5.4 | GO:0060437 | lung growth(GO:0060437) |
1.8 | 3.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.8 | 9.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.8 | 3.5 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.8 | 5.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.7 | 5.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.7 | 3.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.7 | 5.1 | GO:0001927 | exocyst assembly(GO:0001927) |
1.7 | 8.6 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
1.7 | 6.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.7 | 20.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.7 | 3.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.7 | 5.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.6 | 6.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.6 | 6.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.6 | 6.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.6 | 4.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.6 | 12.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.6 | 3.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.6 | 4.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.6 | 4.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.6 | 6.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.5 | 4.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.5 | 4.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.5 | 4.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.5 | 4.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.5 | 3.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.5 | 1.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.5 | 8.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.5 | 1.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.4 | 4.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.4 | 11.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.4 | 4.2 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.4 | 8.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.4 | 5.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.4 | 1.4 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
1.4 | 4.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.4 | 4.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.4 | 4.1 | GO:1901656 | glycoside transport(GO:1901656) |
1.4 | 6.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.4 | 9.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.3 | 6.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.3 | 4.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.3 | 4.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.3 | 6.6 | GO:0022038 | corpus callosum development(GO:0022038) |
1.3 | 1.3 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
1.3 | 3.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.3 | 9.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.3 | 5.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.3 | 3.8 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.3 | 10.2 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
1.3 | 5.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.3 | 3.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.3 | 8.9 | GO:0071625 | vocalization behavior(GO:0071625) |
1.2 | 3.7 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.2 | 6.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.2 | 8.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.2 | 4.9 | GO:0030091 | protein repair(GO:0030091) |
1.2 | 2.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.2 | 6.0 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.2 | 3.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.2 | 3.6 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.2 | 3.6 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.2 | 8.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.2 | 3.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.2 | 4.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.2 | 13.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.2 | 2.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.2 | 5.9 | GO:0035989 | tendon development(GO:0035989) |
1.2 | 2.3 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.2 | 1.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.2 | 3.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.2 | 4.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 3.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.1 | 6.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.1 | 3.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.1 | 3.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.1 | 1.1 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
1.1 | 2.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.1 | 3.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.1 | 3.4 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
1.1 | 4.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.1 | 3.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.1 | 7.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.1 | 2.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.1 | 3.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.1 | 57.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 3.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.1 | 1.1 | GO:0021764 | amygdala development(GO:0021764) |
1.1 | 3.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.1 | 4.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.1 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.1 | 1.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.1 | 3.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.1 | 3.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.0 | 5.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.0 | 3.1 | GO:0090135 | actin filament branching(GO:0090135) |
1.0 | 17.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.0 | 4.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.0 | 6.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 5.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
1.0 | 1.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.0 | 3.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.0 | 3.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.0 | 3.0 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
1.0 | 5.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.0 | 17.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.0 | 1.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.0 | 2.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.0 | 3.9 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
1.0 | 5.8 | GO:0097264 | self proteolysis(GO:0097264) |
1.0 | 3.8 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.0 | 2.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.0 | 1.9 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.9 | 1.9 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.9 | 2.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.9 | 13.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.9 | 9.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 8.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.9 | 0.9 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.9 | 2.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.9 | 1.8 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
0.9 | 12.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.9 | 5.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.9 | 1.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.9 | 4.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.9 | 3.5 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.9 | 2.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.9 | 2.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.9 | 3.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 1.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.8 | 3.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.8 | 1.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.8 | 1.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.8 | 4.2 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.8 | 4.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 2.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 1.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 1.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.8 | 0.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 3.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.8 | 2.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.8 | 5.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 2.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 4.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.8 | 7.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.8 | 1.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.8 | 31.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.8 | 0.8 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.8 | 11.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.8 | 2.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.8 | 0.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.8 | 4.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.8 | 1.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.8 | 2.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 1.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 2.3 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 3.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.8 | 1.5 | GO:0061548 | ganglion development(GO:0061548) |
0.8 | 0.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.8 | 9.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.8 | 0.8 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.8 | 2.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.7 | 3.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 0.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 0.7 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.7 | 4.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 3.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.7 | 5.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.7 | 2.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.7 | 4.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 4.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.7 | 4.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.7 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.7 | 1.5 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.7 | 1.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 0.7 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.7 | 2.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.7 | 6.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 2.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 1.4 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.7 | 4.2 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 1.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.7 | 2.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 2.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.7 | 1.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.7 | 1.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.7 | 0.7 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.7 | 1.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.7 | 2.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.7 | 8.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 5.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.7 | 1.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 1.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.7 | 1.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 2.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.7 | 1.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.7 | 3.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.7 | 2.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.7 | 3.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.7 | 3.9 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.6 | 8.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.6 | 2.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.6 | 11.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.6 | 3.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 1.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.6 | 1.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.6 | 4.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.6 | 4.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.6 | 1.2 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.6 | 1.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 1.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 3.0 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.6 | 7.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.6 | 1.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.6 | 3.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 0.6 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.6 | 3.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.6 | 1.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.6 | 1.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.6 | 0.6 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.6 | 1.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 1.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 4.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.6 | 2.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 1.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 16.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.6 | 1.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.6 | 2.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 1.7 | GO:0060618 | nipple development(GO:0060618) |
0.6 | 1.7 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.6 | 4.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 1.7 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.6 | 1.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.6 | 1.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.6 | 1.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 3.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.6 | 1.7 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.6 | 7.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.6 | 3.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 0.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 1.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.5 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.5 | 4.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 10.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.5 | 1.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 5.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 2.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.5 | 1.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.5 | 1.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 3.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 2.1 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.5 | 4.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.5 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 7.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.5 | 2.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 1.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.5 | 2.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.5 | 1.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.5 | 3.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.5 | 2.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.5 | 5.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 2.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.5 | 1.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 2.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.5 | 2.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 0.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.5 | 1.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 1.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 1.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 0.5 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.5 | 1.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 5.3 | GO:0036065 | fucosylation(GO:0036065) |
0.5 | 1.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.5 | 1.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 1.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 1.9 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.5 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.5 | 0.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.5 | 3.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.5 | 1.9 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.5 | 13.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.5 | 1.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 2.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.5 | 0.5 | GO:1901858 | regulation of mitochondrial DNA replication(GO:0090296) regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.5 | 1.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.5 | 1.4 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.5 | 0.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.5 | 1.4 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.5 | 4.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 32.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 1.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.5 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.5 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 1.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.5 | 1.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 1.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 2.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 3.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 1.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 1.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 4.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 0.9 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.4 | 0.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 0.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 1.3 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.4 | 1.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 2.2 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.4 | 1.3 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 1.3 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.4 | 0.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.4 | 2.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 0.4 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.4 | 1.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 3.5 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 0.9 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 6.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 0.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 2.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 1.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 1.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 8.5 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.4 | 5.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 2.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 6.3 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.4 | 2.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.4 | 2.9 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.4 | 0.8 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 2.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.4 | 2.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 1.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 2.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 1.2 | GO:0030421 | defecation(GO:0030421) |
0.4 | 0.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.4 | 1.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 8.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.4 | 1.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.4 | 2.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 0.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 0.4 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.4 | 0.8 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.4 | 5.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 0.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 0.4 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.4 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 0.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.4 | 1.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 0.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 6.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 1.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 0.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 1.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 0.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.4 | 1.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 0.4 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.4 | 0.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.4 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 1.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 1.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 2.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.4 | 1.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 3.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.4 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 2.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.4 | 1.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 3.9 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.4 | 1.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.3 | 1.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.3 | 4.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 1.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.0 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.3 | 2.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 2.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 0.3 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.3 | 0.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.3 | 0.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.3 | 0.3 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.3 | 2.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 2.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 1.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 0.7 | GO:1900449 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.3 | 1.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 0.3 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.3 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 0.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 1.0 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.3 | 5.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.3 | 1.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 1.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 1.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.3 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 1.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 0.7 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 1.6 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 2.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 0.6 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 1.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 4.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 1.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 0.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.3 | 1.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 0.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.3 | 1.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.6 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.3 | 0.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.3 | 1.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 8.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 0.9 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 2.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 15.9 | GO:0007612 | learning(GO:0007612) |
0.3 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 2.9 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.3 | 0.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 1.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 1.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 0.6 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 2.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 1.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.9 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.3 | 0.8 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.3 | 5.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.3 | 1.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 0.6 | GO:0071673 | regulation of smooth muscle cell chemotaxis(GO:0071671) positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 0.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 0.3 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.3 | 0.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.3 | 1.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 1.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.1 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 3.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 1.3 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.3 | 0.8 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.3 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.3 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 2.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.3 | 1.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.5 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.3 | 1.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 1.0 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 5.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 1.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.3 | 1.8 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.3 | 2.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 1.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.7 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 2.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 2.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 2.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 21.1 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 1.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 1.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.2 | 1.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.9 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.2 | 3.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.2 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.9 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.7 | GO:0014889 | muscle atrophy(GO:0014889) |
0.2 | 1.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 3.2 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.7 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.9 | GO:0086009 | membrane repolarization(GO:0086009) |
0.2 | 2.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 1.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.4 | GO:1900094 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 1.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.6 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 5.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 3.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.2 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 2.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.2 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 0.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 2.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 1.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 6.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 1.3 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.5 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.7 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 3.7 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.2 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.2 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 1.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 1.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 1.0 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 0.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 0.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 2.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 1.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 3.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.2 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.9 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.4 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 1.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 1.0 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 1.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.3 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.5 | GO:0001736 | establishment of planar polarity(GO:0001736) |
0.1 | 1.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.1 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.7 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.5 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 1.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 3.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.5 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 1.6 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 3.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.3 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.5 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 2.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.4 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 4.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 1.0 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 1.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.4 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.1 | 0.3 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.3 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.8 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.3 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.5 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.2 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.7 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.7 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 1.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.0 | 0.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.0 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 1.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.0 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.0 | 0.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.0 | 0.0 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.1 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.2 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.2 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 1.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.2 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.0 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.1 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:2000846 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.2 | GO:0072534 | perineuronal net(GO:0072534) |
3.7 | 11.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
3.5 | 10.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.3 | 6.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.7 | 13.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.7 | 21.5 | GO:0043083 | synaptic cleft(GO:0043083) |
2.5 | 25.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.3 | 16.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.0 | 6.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.8 | 12.7 | GO:0071437 | invadopodium(GO:0071437) |
1.8 | 5.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.7 | 19.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.7 | 5.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.6 | 24.4 | GO:0031527 | filopodium membrane(GO:0031527) |
1.5 | 4.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.5 | 12.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.4 | 8.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.4 | 4.1 | GO:0032280 | symmetric synapse(GO:0032280) |
1.3 | 4.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.3 | 23.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.3 | 7.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 34.7 | GO:0044295 | axonal growth cone(GO:0044295) |
1.2 | 3.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.2 | 3.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.2 | 2.3 | GO:0097441 | basilar dendrite(GO:0097441) |
1.1 | 14.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.1 | 49.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.1 | 3.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.1 | 4.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.0 | 7.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.0 | 3.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.0 | 12.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.0 | 3.0 | GO:0043511 | inhibin complex(GO:0043511) |
1.0 | 5.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.0 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 4.7 | GO:0005883 | neurofilament(GO:0005883) |
0.9 | 36.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 2.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.9 | 10.2 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 12.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.9 | 2.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 23.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.9 | 2.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.9 | 2.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.9 | 8.8 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.8 | 4.2 | GO:0000235 | astral microtubule(GO:0000235) |
0.8 | 2.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.8 | 6.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.8 | 5.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.8 | 3.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 5.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 3.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.8 | 7.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 2.2 | GO:0071942 | XPC complex(GO:0071942) |
0.7 | 1.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 2.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.7 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 4.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 24.5 | GO:0030175 | filopodium(GO:0030175) |
0.7 | 8.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.7 | 2.0 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.7 | 37.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 1.9 | GO:0000802 | transverse filament(GO:0000802) |
0.6 | 2.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 2.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 55.7 | GO:0030426 | growth cone(GO:0030426) |
0.6 | 1.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 9.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.6 | 36.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.6 | 3.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 2.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 12.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 13.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 2.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 3.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 1.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 64.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 3.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 8.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 2.5 | GO:0097433 | dense body(GO:0097433) |
0.5 | 2.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 2.3 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 5.1 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 6.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 2.3 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 1.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 2.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 3.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.4 | 1.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 0.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 2.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.4 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 1.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 1.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 1.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 2.6 | GO:0070187 | telosome(GO:0070187) |
0.4 | 1.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 9.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.4 | 2.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 1.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 3.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 3.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 3.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 2.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 3.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 5.2 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 1.5 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.3 | 3.0 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 1.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 2.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.3 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.3 | 3.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 1.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 2.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 0.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 2.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 3.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 1.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 1.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.7 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 4.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 12.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 8.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 2.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.7 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 8.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 2.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 1.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.1 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.5 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 2.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 12.2 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 3.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 4.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 1.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.4 | 22.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
5.7 | 17.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.2 | 21.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.6 | 14.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.1 | 9.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
2.8 | 14.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.7 | 8.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.6 | 12.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.5 | 9.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.4 | 14.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.3 | 7.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.3 | 9.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.2 | 6.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.2 | 11.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.1 | 16.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.0 | 17.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.9 | 9.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.9 | 1.9 | GO:0003896 | DNA primase activity(GO:0003896) |
1.8 | 5.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.8 | 19.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.7 | 6.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.6 | 9.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.6 | 4.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.6 | 3.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.5 | 15.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.5 | 4.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.5 | 3.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.5 | 3.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.5 | 9.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.5 | 5.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.5 | 4.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.4 | 4.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.4 | 4.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.4 | 1.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.4 | 4.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.4 | 4.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.3 | 5.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.3 | 9.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.3 | 6.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.2 | 6.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.2 | 3.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.2 | 9.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.2 | 6.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.2 | 4.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.2 | 20.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.2 | 3.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.2 | 5.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.1 | 10.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 10.0 | GO:0038191 | neuropilin binding(GO:0038191) |
1.1 | 9.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.1 | 3.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.1 | 3.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.1 | 2.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 3.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.0 | 3.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.0 | 8.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 17.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.0 | 10.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.0 | 2.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.0 | 3.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.9 | 4.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.9 | 3.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 3.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 10.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.9 | 4.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.9 | 18.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.9 | 0.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.9 | 1.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 1.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.8 | 6.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 2.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 3.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.8 | 5.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.8 | 3.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.8 | 2.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 17.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 13.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.8 | 28.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 2.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.8 | 2.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 3.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.8 | 3.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.8 | 3.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.8 | 2.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.8 | 5.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 2.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 2.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 0.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.7 | 2.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.7 | 1.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 1.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 2.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 2.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 9.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 2.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.7 | 2.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 5.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.7 | 5.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.7 | 3.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 3.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.7 | 1.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 2.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 2.6 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.6 | 4.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 12.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 6.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 1.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 4.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.6 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 4.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.6 | 2.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 5.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.6 | 1.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 8.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 2.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.6 | 15.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.6 | 16.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 2.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.6 | 2.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 2.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 2.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.6 | 1.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.6 | 2.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 1.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.6 | 13.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 1.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 1.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 8.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 3.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 1.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 1.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 5.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 2.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 2.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 1.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 1.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.5 | 4.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.5 | 4.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.5 | 2.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 1.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 4.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 2.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 3.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 2.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 2.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 4.9 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 1.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 10.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 1.6 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 4.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 4.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 12.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 1.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 3.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 1.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.4 | 4.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 1.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 4.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 2.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 2.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 3.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 0.7 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 3.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 7.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 0.3 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.3 | 2.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 2.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.3 | 0.7 | GO:0016595 | glutamate binding(GO:0016595) |
0.3 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 7.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 6.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 0.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 3.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 0.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 7.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 1.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 0.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 6.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 2.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.9 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 1.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 2.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 0.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 5.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 3.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 0.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 0.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 1.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.3 | 2.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 10.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 3.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 6.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 2.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 2.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 5.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 4.9 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 2.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 4.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 1.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 4.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 2.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 2.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 3.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 4.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 4.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 1.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 5.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 2.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 3.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 5.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 1.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 0.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 2.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 2.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 2.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 2.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 0.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 3.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 7.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 0.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 3.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 4.5 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 6.1 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 10.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 2.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.6 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.4 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 1.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 14.8 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 3.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 1.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.1 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 5.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 1.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 3.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.6 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0018598 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 2.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 21.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 3.2 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 4.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 1.0 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 1.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 5.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 2.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 1.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.0 | 0.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 4.8 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 37.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.0 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 0.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.9 | 19.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.8 | 2.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.8 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 11.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 7.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 7.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 7.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 4.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 1.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 7.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 5.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 5.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.7 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 6.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 6.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 4.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 5.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 6.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 4.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.9 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 3.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 5.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 3.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.7 | 7.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.6 | 22.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.5 | 18.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.5 | 4.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.2 | 18.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 17.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.2 | 13.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 46.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 11.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.0 | 18.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.0 | 2.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.9 | 7.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.9 | 2.7 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.9 | 27.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 16.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 20.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.8 | 11.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 3.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 5.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 1.6 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.8 | 6.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 18.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 3.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.8 | 1.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.7 | 5.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.7 | 7.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.7 | 1.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.7 | 8.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 9.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 8.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 4.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 10.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.6 | 6.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 6.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 9.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 5.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 3.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 2.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 7.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 4.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 6.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 8.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 4.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 2.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 4.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 3.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 3.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 14.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 6.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 3.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 4.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 3.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 2.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 1.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 3.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 3.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 6.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 0.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 2.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.3 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 11.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 3.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 8.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 2.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 12.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 11.1 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 0.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.1 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.1 | 2.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 2.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 3.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 3.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |